Author
Listed:
- Xingming Zhang
(Sichuan University)
- Junjie Zhao
(Sichuan University)
- Xiaoxue Yin
(Sichuan University)
- Jiayu Liang
(Sichuan University)
- Yongquan Wang
(Army Medical University)
- Linmao Zheng
(Sichuan University)
- Ping Tan
(Sichuan University)
- Yifei Lin
(Sichuan University
Sichuan University)
- Nanwei Xu
(Sichuan University)
- Sha Zhu
(Sichuan University)
- Junru Chen
(Sichuan University)
- Jinge Zhao
(Sichuan University)
- Xu Hu
(Sichuan University)
- Xiuyi Pan
(Sichuan University)
- Ling Nie
(Sichuan University)
- Mengni Zhang
(Sichuan University)
- Yuntian Chen
(Sichuan University)
- Yaowen Zhang
(Sichuan University)
- Haoyang Liu
(Sichuan University)
- Jindong Dai
(Sichuan University)
- Zhipeng Wang
(Sichuan University)
- Haolin Liu
(Sichuan University)
- Yuchao Ni
(Sichuan University)
- Niels J. Rupp
(University Hospital Zurich
University of Zurich)
- Holger Moch
(University Hospital Zurich
University of Zurich)
- Xinan Sheng
(Peking University Cancer Hospital and Institute)
- Kan Gong
(Peking University First Hospital)
- Xiaodong Liu
(The First Affiliated Hospital of Kunming Medical University)
- Zhibin Chen
(The First People’s Hospital of Neijiang)
- Zhengyu He
(Yaan People’s Hospital)
- Yaodong Wang
(Mianyang Central Hospital)
- Lijing Xu
(Sichuan University)
- Mingsheng Liu
(Affiliated Qujing Hospital of Kunming Medical University)
- Hongqing Zhou
(Affiliated Qujing Hospital of Kunming Medical University)
- Bo Tang
(Sichuan University)
- Rui Huang
(Sichuan University)
- Qiang Wei
(Sichuan University)
- Xiang Li
(Sichuan University)
- Jiyan Liu
(Sichuan University)
- Jin Yao
(Army Medical University)
- Banghua Liao
(Sichuan University)
- Zhenhua Liu
(Sichuan University)
- Pengfei Shen
(Sichuan University)
- Ni Chen
(Sichuan University)
- Hao Zeng
(Sichuan University)
- Guangxi Sun
(Sichuan University)
Abstract
Fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) is a rare yet highly lethal kidney cancer. To deepen our understanding of FH-deficient RCC, we conduct a comprehensive integrated genomic study. We analyze the association of FH alteration patterns with tumor heterogeneity and develop a CpG site-specific methylation signature for precise identification of FH-deficient RCC. Transcriptomic analysis unveils three distinctive molecular subtypes characterized by enrichment of immune/Angiogenic/Stromal (C1), WNT/Notch/MAPK (C2), and proliferation/stemness (C3) pathways, respectively. Tumors in C1 derive the most substantial survival benefit from a combination of immune checkpoint blockade (ICB) and anti-angiogenic therapy. Tumors in C2 display moderate response to this therapeutic approach. In contrast, tumors in C3 exhibit an unfavorable response to anti-angiogenic monotherapy and its combination with ICB. These findings contribute to a profound understanding of the aggressive nature of FH-deficient RCC, offering insights into potential precision medicine approaches for disease management.
Suggested Citation
Xingming Zhang & Junjie Zhao & Xiaoxue Yin & Jiayu Liang & Yongquan Wang & Linmao Zheng & Ping Tan & Yifei Lin & Nanwei Xu & Sha Zhu & Junru Chen & Jinge Zhao & Xu Hu & Xiuyi Pan & Ling Nie & Mengni Z, 2025.
"Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets,"
Nature Communications, Nature, vol. 16(1), pages 1-19, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59513-8
DOI: 10.1038/s41467-025-59513-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59513-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.